KRAS and colorectal carcinoma: Lal et al. analyzed The Cancer Genome Atlas (TGCA) CRC datasets and reported decreased infiltration of cytotoxic cells and a reduced Th1-mediated immune response in patients with KRAS-mutant tumors 140.